URGN / UroGen Pharma Ltd. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

UroGen Pharma Ltd.
US ˙ NasdaqGM ˙ IL0011407140

Deler fremragende 48,708,280 shares
Insideraktier3.836.281 shares
Insider ejerskab7,88 %
Total Insiders23
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-2 ( )
9967 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.038% ( )
9873 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

UroGen Pharma Ltd. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ron Bentsur Chief Executive Officer, Director - [D] [O] 76.226 76.226
Cynthia M Butitta Director - [D] 2.000 2.000
Barrett Elizabeth A. Chief Executive Officer - [O] 326.691 326.691
Arie Belldegrun Director - [D] 408.693 408.693
Fred E Cohen Director - [D] 69.339 69.339
Chris Degnan Chief Financial Officer - [O] 2.280 2.280
Kathryn E Falberg 10.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Molly Henderson Chief Financial Officer - [O] 5.248 5.248
Stuart Holden Director - [D] 2.000 2.000
Dong Kim Chief Financial Officer - [O] 37.753 37.753
Jay Moorin 10% Owner - [10%] 1.242.031 1.242.031
Stephen Mullennix Chief Operating Officer - [O] 10.084 10.084
Ran Nussbaum Director - [D] 1.434.958 1.434.958
Pfreundschuh Peter P. Chief Financial Officer - [O] 10.405 10.405
ProQuest Associates IV LLC 10% Owner - [10%] 1.242.031 1.242.031
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
ProQuest Investments IV, L.P. 10% Owner - [10%] 1.242.031 1.242.031
Robinson James A. Jr. Director - [D] 4.000 4.000
Alain Schreiber 10% Owner - [10%] 1.242.031 1.242.031
Mark Schoenberg Chief Medical Officer - [O] 144.985 144.985
Jason Drew Smith General Counsel - [O] 55.588 55.588
Shawn Tomasello 10.000
Leana Wen Director - [D] 2.000 2.000
Daniel George Wildman Director - [D] 2.000 2.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i URGN / UroGen Pharma Ltd.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-11-18 Schoenberg Mark 160 13,1000 160 13,1000 2.096 6 12.76 -54 -2,60
2021-05-17 Henderson Molly 2.500 15,8500 2.500 15,8500 39.625
2021-05-17 Smith Jason Drew 2.500 15,7100 2.500 15,7100 39.275
2020-12-14 Barrett Elizabeth A. 10.000 18,5000 10.000 18,5000 185.000
2019-11-21 Barrett Elizabeth A. 7.530 28,0000 7.530 28,0000 210.840
2019-11-20 Barrett Elizabeth A. 7.470 28,0000 7.470 28,0000 209.160
2019-11-19 Schoenberg Mark 1.960 28,1700 1.960 28,1700 55.213
2019-11-15 Barrett Elizabeth A. 1.548 26,0000 1.548 26,0000 40.248
2019-03-21 Schoenberg Mark 272 37,0090 272 37,0090 10.066

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

URGN / UroGen Pharma Ltd. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i URGN / UroGen Pharma Ltd.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-02-03 Smith Jason Drew 2.654 19,6900 2.654 19,6900 52.257 55 17.0000 -7.139 -13,66
2026-02-03 Smith Jason Drew 1.608 19,6900 1.608 19,6900 31.662
2026-02-03 Smith Jason Drew 3.217 19,6900 3.217 19,6900 63.343
2026-02-03 Schoenberg Mark 1.843 19,6900 1.843 19,6900 36.289
2026-02-03 Schoenberg Mark 3.686 19,6900 3.686 19,6900 72.577
2026-02-03 Schoenberg Mark 1.844 19,6900 1.844 19,6900 36.308
2025-10-08 Degnan Chris 2.203 16,8500 2.203 16,8500 37.121
2025-09-08 Schoenberg Mark 871 19,1100 871 19,1100 16.645
2025-09-08 Smith Jason Drew 1.520 19,1100 1.520 19,1100 29.047

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

URGN / UroGen Pharma Ltd. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-02-27 2025-02-26 4 Robinson James A. Jr. URGN ordinary shares M - Exercise D 2.000 4.000
2026-02-11 2026-02-03 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,6900 -3.217 -63 55.588
2026-02-11 2026-02-03 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,6900 -1.608 -32 51.326
2026-02-11 2026-02-03 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,6900 -2.654 -52 52.934
2026-02-11 2026-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 6.667 49.972
2026-02-11 2026-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 3.333 58.805
2026-02-11 2026-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 5.500 55.472
2026-02-04 2026-02-03 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6900 -3.686 -73 144.985
2026-02-04 2026-02-03 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6900 -1.843 -36 148.671
2026-02-04 2026-02-03 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6900 -1.844 -36 150.514
2026-02-03 2026-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3.334 142.359
2026-02-03 2026-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 6.666 152.358
2026-02-03 2026-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3.333 145.692
2025-12-01 2025-11-26 4 Holden Stuart URGN ordinary shares M - Exercise D 2.000 2.000
2025-12-01 2025-11-26 4 BUTITTA CYNTHIA M URGN ordinary shares M - Exercise D 2.000 2.000
2025-12-01 2025-11-26 4 Robinson James A. Jr. URGN ordinary shares M - Exercise D 2.000 2.000
2025-12-01 2025-11-26 4 WEN LEANA URGN ordinary shares M - Exercise D 2.000 2.000
2025-12-01 2025-11-26 4 Wildman Daniel George URGN ordinary shares M - Exercise D 2.000 2.000
2025-11-20 2025-11-19 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 25,0000 -10.000 -250 139.025
2025-10-09 2025-10-08 4 Degnan Chris URGN Ordinary Shares S - Sale D 16,8500 -2.203 -37 2.280
2025-10-09 2025-10-08 4 Degnan Chris URGN Ordinary Shares M - Exercise D 4.483 4.483
2025-09-09 2025-09-08 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,1100 -871 -17 149.025
2025-09-09 2025-09-07 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.667 149.896
2025-09-09 2025-09-08 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,1100 -1.520 -29 43.305
2025-09-09 2025-09-07 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 3.333 44.825
2025-08-13 2025-08-11 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 17,6900 -10.000 -177 148.229
2025-07-30 2025-07-28 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,1400 -7.522 -144 41.492
2025-07-30 2025-07-28 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 16.500 49.014
2025-07-30 2025-07-28 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,1400 -5.149 -99 158.229
2025-07-30 2025-07-28 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 10.000 163.378
2025-06-11 2025-06-09 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,3700 -5.162 -38 153.378
2025-06-11 2025-06-08 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 10.000 158.540
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,1400 -1.896 -21 148.540
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,1400 -1.896 -21 148.540
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3.333 150.436
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3.333 150.436
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,1400 -759 -8 145.666
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.334 146.425
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 11,1400 -2.767 -31 32.514
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 5.500 35.281
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 11,1400 -3.354 -37 29.781
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 6.667 33.135
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 11,1400 -1.258 -14 26.468
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 2.500 27.726
2024-09-12 2024-09-09 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 13,0800 -859 -11 145.091
2024-09-12 2024-09-09 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.666 145.950
2024-09-12 2024-09-09 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 13,0800 -1.521 -20 25.226
2024-09-12 2024-09-09 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 3.333 26.747
2024-09-12 2024-09-09 4 Kim Dong URGN Ordinary Shares M - Exercise D 2.500 37.753
2024-06-11 2024-06-10 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 13,0800 -5.153 -67 144.284
2024-06-11 2024-06-10 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 10.000 149.437
2024-03-20 2024-03-18 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 14,0500 -12.000 -169 139.437
2024-02-12 2024-01-31 4/A Kim Dong URGN Ordinary Shares M - Exercise D 3.333 35.253
2024-02-05 2024-02-01 4/A Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7800 -3.328 -53 23.414
2024-02-05 2024-02-01 4/A Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7800 -1.248 -20 20.076
2024-02-05 2024-02-01 4/A Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7800 -417 -7 18.824
2024-02-05 2024-02-01 4/A Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7800 -1.894 -30 151.437
2024-02-05 2024-02-01 4/A Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7800 -758 -12 149.998
2024-02-05 2024-02-01 4/A Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7800 -1.137 -18 149.423
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7400 -3.328 -52 23.414
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 6.666 26.742
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7400 -1.248 -20 20.076
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 2.500 21.324
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7400 -417 -7 18.824
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 834 19.241
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7400 -1.894 -30 151.437
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3.333 153.331
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7400 -758 -12 149.998
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.333 150.756
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7400 -1.137 -18 149.423
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2.000 150.560
2024-02-02 2024-01-31 4 Kim Dong URGN Ordinary Shares M - Exercise D 3.333 26.585
2023-09-05 2023-08-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 18,0100 -3.800 -68 18.407
2023-09-05 2023-08-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 8.334 22.207
2023-07-28 2023-07-26 4 Cohen Fred E by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer URGN Ordinary Shares A - Award I 9,5400 69.339 661 69.339
2023-02-28 2022-06-06 4/A Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. URGN Ordinary Shares M - Exercise I 5,0000 1.030 5 1.434.958
2023-02-28 2022-10-21 4/A Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd URGN Ordinary Shares M - Exercise I 5,9400 47.999 285 1.485.168
2023-02-28 2022-06-16 4 Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. URGN Ordinary Shares M - Exercise I 5,0000 2.211 11 1.437.169
2023-02-02 2023-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 13.333 326.691
2023-02-02 2023-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 5.000 313.358
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 10,1200 -1.227 -12 13.873
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 2.500 15.100
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 10,1200 -409 -4 12.600
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 833 13.009
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 10,1200 -661 -7 148.560
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.333 149.221
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 10,1200 -991 -10 147.888
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2.000 148.879
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 10,1200 -248 -3 146.879
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 147.127
2023-01-23 2023-01-20 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 5,0000 122.677 613 146.627
2022-11-02 2022-10-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,8500 -258 -3 23.950
2022-11-02 2022-10-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 24.208
2022-10-25 2022-10-21 4 Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd URGN Ordinary Shares M - Exercise I 5,9400 47.999 285 1.481.927
2022-09-16 2022-09-14 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 160.000 800 408.693
2022-09-02 2022-08-31 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 3.241 16 248.693
2022-09-02 2022-08-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 7,2100 -3.606 -26 12.176
2022-09-02 2022-08-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 8.333 15.782
2022-08-25 2022-06-06 4 Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. URGN Ordinary Shares M - Exercise I 5,0000 1.030 5 1.433.928
2022-08-25 2022-08-01 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,8100 -259 -2 23.708
2022-08-25 2022-07-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 23.967
2022-05-03 2022-04-30 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -500 1.500
2022-05-03 2022-04-30 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 6,6200 -254 -2 23.467
2022-05-03 2022-04-30 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 23.721
2022-03-29 2022-03-25 4 Kim Dong URGN Employee Stock Option (right to buy) A - Award D 8,61 30.000 30.000
2022-03-29 3 Kim Dong URGN Ordinary Shares D 31.920
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Stock Option (right to buy) A - Award D 7,72 30.000 30.000
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Restricted Stock Units A - Award D 7.500 7.500
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Restricted Stock Units M - Exercise D -833 1.667
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 7,5800 -414 -3 7.449
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 833 7.863
2022-02-02 2022-01-31 4 Henderson Molly URGN Stock Option (right to buy) A - Award D 7,72 30.000 30.000
2022-02-02 2022-01-31 4 Henderson Molly URGN Restricted Stock Units A - Award D 7.500 7.500
2022-02-02 2022-01-31 4 Henderson Molly URGN Restricted Stock Units M - Exercise D -666 1.334
2022-02-02 2022-01-31 4 Henderson Molly URGN Ordinary Shares S - Sale D 7,5800 -331 -3 5.248
2022-02-02 2022-01-31 4 Henderson Molly URGN Ordinary Shares M - Exercise D 666 5.579
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Stock Option (right to buy) A - Award D 7,72 150.000 150.000
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -13.333 26.667
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -5.000 5.000
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares S - Sale D 7,5800 -5.960 -45 308.358
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 13.333 314.318
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares S - Sale D 7,5800 -2.235 -17 300.985
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 5.000 303.220
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Restricted Stock M - Exercise D -2.000 4.000
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Restricted Stock Units A - Award D 4.000 4.000
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Stock Option (right to buy) A - Award D 7,72 12.064 12.064
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -500 2.000
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,5800 -1.099 -8 23.221
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2.000 24.320
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,5800 -275 -2 22.320
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 22.595
2022-01-28 2022-01-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -209 0
2022-01-28 2022-01-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 8,0900 -111 -1 22.095
2022-01-28 2022-01-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 209 22.206
2022-01-07 2022-01-04 4 Barrett Elizabeth A. URGN Ordinary Shares S - Sale D 9,1500 -46.968 -430 298.220
2022-01-07 2022-01-03 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -105.689 0
2022-01-07 2022-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 105.689 345.188
2021-12-02 2021-11-30 4 Smith Jason Drew URGN Restricted Stock Units M - Exercise D -8.333 16.667
2021-12-02 2021-11-30 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 12,0300 -3.803 -46 7.030
2021-12-02 2021-11-30 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 8.333 10.833
2021-12-02 2021-11-30 4 Henderson Molly URGN Restricted Stock Units M - Exercise D -5.000 10.000
2021-12-02 2021-11-30 4 Henderson Molly URGN Ordinary Shares S - Sale D 12,0300 -2.587 -31 4.913
2021-12-02 2021-11-30 4 Henderson Molly URGN Ordinary Shares M - Exercise D 5.000 7.500
2021-11-19 2021-11-18 4 Schoenberg Mark URGN Ordinary Shares P - Purchase D 13,1000 160 2 21.997
2021-11-02 2021-11-01 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 17,1600 -258 -4 21.837
2021-11-02 2021-10-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -500 2.500
2021-11-02 2021-10-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 22.095
2021-10-28 2021-10-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 16,3200 -107 -2 21.595
2021-10-28 2021-10-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -208 209
2021-10-28 2021-10-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 21.702
2021-08-03 2021-08-02 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,6400 -243 -4 21.494
2021-08-03 2021-07-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -500 3.000
2021-08-03 2021-07-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 21.737
2021-07-28 2021-07-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -208 417
2021-07-28 2021-07-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,3000 -103 -2 20.821
2021-07-28 2021-07-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D -208 20.924
2021-07-12 2020-12-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.808 114.496
2021-07-12 2020-12-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.808 219.117
2021-07-12 2020-11-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.808 123.304
2021-07-12 2020-11-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.808 210.309
2021-07-12 2020-10-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.808 132.112
2021-07-12 2020-10-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.808 201.501
2021-07-12 2020-09-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 140.920
2021-07-12 2020-09-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 192.693
2021-07-12 2020-08-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 149.727
2021-07-12 2020-08-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 183.886
2021-07-12 2020-07-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 158.534
2021-07-12 2020-07-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 175.079
2021-07-12 2020-06-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 167.341
2021-07-12 2020-06-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 166.272
2021-07-12 2020-05-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.808 176.148
2021-07-12 2020-05-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.808 157.465
2021-07-12 2020-04-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 198.956
2021-07-12 2020-04-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 148.657
2021-07-12 2020-03-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 193.763
2021-07-12 2020-03-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 139.850
2021-07-12 2020-02-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 202.570
2021-07-12 2020-02-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 131.043
2021-06-09 2021-03-26 4/A Belldegrun Arie URGN Stock Option (right to buy) M - Exercise D 5,00 -3.241 0
2021-06-09 2021-03-26 4/A Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 3.241 16 245.452
2021-06-09 2021-03-25 4/A Nussbaum Ran By Pontifax Cayman III Limited Partnership URGN Stock Option (right to buy) M - Exercise I 5,00 -1.030 0
2021-06-09 2021-03-25 4/A Nussbaum Ran Managing Partner of entities affiliated with Pontifax Management III G.P. ( URGN Ordinary Shares M - Exercise I 5,0000 1.030 5 1.431.717
2021-06-09 2021-06-07 4 Cohen Fred E URGN Stock Option (right to buy) A - Award D 17,98 10.000 10.000
2021-06-09 2021-06-07 4 FALBERG KATHRYN E URGN Stock Option (right to buy) A - Award D 17,98 10.000 10.000
2021-06-09 2021-06-07 4 BUTITTA CYNTHIA M URGN Stock Option (right to buy) A - Award D 17,98 10.000 10.000
2021-06-09 2021-06-07 4 Nussbaum Ran By Pontifax Cayman III Limited Partnership URGN Stock Option (right to buy) A - Award I 17,89 3.183 3.183
2021-06-09 2021-06-07 4 Nussbaum Ran by Pontifax (Israel) III Limited Partnership URGN Stock Option (right to buy) A - Award I 17,89 6.817 6.817
2021-06-09 2021-03-25 4 Nussbaum Ran by Pontifax (Israel) III Limited Partnership URGN Stock Option (right to buy) M - Exercise I 5,00 -2.211 0
2021-06-09 2021-03-25 4 Nussbaum Ran Managing Partner of entities affiliated with Pontifax Management III G.P. URGN Ordinary Shares M - Exercise I 5,0000 2.211 11 1.433.928
2021-06-09 2021-06-07 4 Belldegrun Arie URGN Stock Option (right to buy) A - Award D 17,98 10.000 10.000
2021-06-09 2021-06-07 4 Tomasello Shawn URGN Stock Option (right to buy) A - Award D 17,98 10.000 10.000
2021-06-09 2021-06-07 4 Holden Stuart URGN Stock Option (right to buy) A - Award D 17,98 10.000 10.000
2021-06-08 2021-06-05 4 Smith Jason Drew URGN Stock Option (right to buy) A - Award D 17,98 15.000 15.000
2021-06-08 2021-06-05 4 Henderson Molly URGN Stock Option (right to buy) A - Award D 17,98 15.000 15.000
2021-05-21 2021-05-19 4 Barrett Elizabeth A. URGN Ordinary Shares F - Taxes D 17,5089 -1.240 -22 239.499
2021-05-21 2021-05-19 4 Barrett Elizabeth A. URGN Ordinary Shares F - Taxes D 17,5089 -2.185 -38 240.739
2021-05-21 2021-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -5.000 10.000
2021-05-21 2021-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 5.000 242.924
2021-05-21 2021-01-03 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -8.807 105.689
2021-05-21 2021-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8.807 237.924
2021-05-18 2021-05-17 4 Henderson Molly URGN Common Stock P - Purchase D 15,8500 2.500 40 2.500
2021-05-18 2021-05-17 4 Smith Jason Drew URGN Common Stock P - Purchase D 15,7100 2.500 39 2.500
2021-05-04 2021-04-30 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -500 3.500
2021-05-04 2021-04-30 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 20,0000 -243 -5 21.132
2021-05-04 2021-04-30 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 21.375
2021-04-27 2021-04-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -209 625
2021-04-27 2021-04-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6300 -89 -2 20.875
2021-04-27 2021-04-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 209 20.964
2021-04-22 2021-03-24 4 Belldegrun Arie URGN Stock Option (right to buy) M - Exercise D 5,00 -3.241 0
2021-04-22 2021-03-24 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 3.241 16 245.452
2021-04-22 2021-03-24 4 Nussbaum Ran By Pontifax Cayman III Limited Partnership URGN Stock Option (right to buy) M - Exercise I 5,00 -1.030 0
2021-04-22 2021-03-24 4 Nussbaum Ran Managing Partner of entities affiliated with Pontifax Management III G.P. ( URGN Ordinary Shares M - Exercise I 5,0000 1.030 5 1.465.199
2021-02-02 2021-01-31 4 Henderson Molly URGN Restricted Stock Units A - Award D 2.000 2.000
2021-02-02 2021-01-31 4 Henderson Molly URGN Stock Option (right to buy) A - Award D 22,07 6.000 6.000
2021-02-02 2021-01-31 4 Smith Jason Drew URGN Restricted Stock Units A - Award D 2.500 2.500
2021-02-02 2021-01-31 4 Smith Jason Drew URGN Stock Option (right to buy) A - Award D 22,07 8.000 8.000
2021-02-02 2021-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units A - Award D 40.000 40.000
2021-02-02 2021-01-31 4 Barrett Elizabeth A. URGN Stock Option (right to buy) A - Award D 22,07 150.000 150.000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Restricted Stock Units A - Award D 6.000 6.000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Stock Option (right to buy) A - Award D 22,07 21.000 21.000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -2.000 4.000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 22,0700 -1.076 -24 20.755
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2.000 21.831
2021-01-26 2021-01-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -208 834
2021-01-26 2021-01-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 22,1200 -100 -2 19.831
2021-01-26 2021-01-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 19.931
2020-12-15 2020-12-14 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 18,5000 10.000 185 229.117
2020-12-07 2020-12-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -1.042 0
2020-12-07 2020-12-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,8500 -662 -13 19.723
2020-12-07 2020-12-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.042 20.385
2020-12-04 2020-12-04 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -61.652 114.496
2020-12-04 2020-12-04 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 61.652 219.117
2020-10-28 2020-10-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -208 1.042
2020-10-28 2020-10-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 20,9461 -101 -2 19.343
2020-10-28 2020-10-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 19.444
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -2.000 4.000
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -2.084 2.082
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -833 1.667
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 21,7200 -1.017 -22 10.405
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 21,8243 -407 -9 11.422
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 21,7992 -976 -21 11.829
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 4.917 12.805
2020-10-05 2020-10-01 4/A Smith Jason Drew URGN Restricted Stock Unit A - Award D 25.000 25.000
2020-10-05 2020-10-01 4/A Smith Jason Drew URGN Employee Stock Option (right to buy) A - Award D 19,66 60.000 60.000
2020-10-05 2020-10-01 4 Henderson Molly URGN Restricted Stock Units A - Award D 15.000 15.000
2020-10-05 2020-10-01 4 Henderson Molly URGN Stock Option (Right to Buy) A - Award D 19,66 60.000 60.000
2020-09-10 2020-09-09 4 Smith Jason Drew URGN Restricted Stock Unit A - Award D 25.000 25.000
2020-09-10 2020-09-09 4 Smith Jason Drew URGN Employee Stock Option (right to buy) A - Award D 21,38 60.000 60.000
2020-09-08 2020-09-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -1.041 1.042
2020-09-08 2020-09-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 20,2000 -348 -7 19.236
2020-09-08 2020-09-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.041 19.584
2020-09-01 2020-09-01 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -1.042 4.166
2020-09-01 2020-09-01 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 22,8200 -509 -12 7.888
2020-09-01 2020-09-01 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1.042 8.397
2020-07-28 2020-07-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 23,5100 -70 -2 18.543
2020-07-28 2020-07-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -209 1.250
2020-07-28 2020-07-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 209 18.613
2020-07-28 2020-07-27 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 23,5100 -141 -3 7.355
2020-07-28 2020-07-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -417 2.500
2020-07-28 2020-07-26 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 417 7.496
2020-06-10 2020-06-08 4 Belldegrun Arie URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-10 2020-06-08 4 BUTITTA CYNTHIA M URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-10 2020-06-08 4 Cohen Fred E URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-10 2020-06-08 4 FALBERG KATHRYN E URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-10 2020-06-08 4 Holden Stuart URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-10 2020-06-08 4 Nussbaum Ran URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-10 2020-06-08 4 Tomasello Shawn URGN Stock Option (right to buy) A - Award D 28,24 10.000 10.000
2020-06-05 2020-06-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -1.042 2.083
2020-06-05 2020-06-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 27,5128 -349 -10 18.404
2020-06-05 2020-06-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.042 18.753
2020-05-20 2020-05-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -1.041 5.208
2020-05-20 2020-05-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 25,0700 -358 -9 7.079
2020-05-20 2020-05-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1.041 7.437
2020-05-14 2020-05-12 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D -35.229 176.148
2020-05-14 2020-05-12 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 35.229 157.465
2020-04-28 2020-04-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 24,3500 -70 -2 17.711
2020-04-28 2020-04-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -208 1.459
2020-04-28 2020-04-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 17.781
2020-04-28 2020-04-27 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 24,3500 -141 -3 6.396
2020-04-28 2020-04-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -417 2.917
2020-04-28 2020-04-26 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 417 6.537
2020-04-28 2020-04-27 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 24,3500 -145 -4 10.084
2020-04-28 2020-04-26 4 Mullennix Stephen URGN Restricted Stock Units (RSUs) M - Exercise D -417 2.917
2020-04-28 2020-04-26 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 417 10.229
2020-03-04 2020-03-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D -1.042 3.125
2020-03-04 2020-03-04 4 Schoenberg Mark URGN Ordinary Shares F - Taxes D 29,5000 -345 -10 17.573
2020-03-04 2020-03-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.042 17.918
2020-02-24 2020-02-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -1.042 6.249
2020-02-24 2020-02-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 29,6800 -360 -11 6.120
2020-02-24 2020-02-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1.042 6.480
2020-02-18 2020-02-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D -1.759 7.037
2020-02-18 2020-02-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 28,0400 -612 -17 9.812
2020-02-18 2020-02-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1.759 10.424
2020-02-13 3/A Belldegrun Arie URGN Ordinary Shares D 114.211
2020-02-13 3/A Schoenberg Mark URGN Ordinary Shares D 12.986
2020-02-04 2020-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Unit A - Award D 15.000 15.000
2020-02-04 2020-01-31 4 Barrett Elizabeth A. URGN Stock options (right to buy) A - Award D 29,41 45.000 45.000
2020-02-04 2020-01-31 4 Schoenberg Mark URGN Restricted stock unit A - Award D 6.000 6.000
2020-02-04 2020-01-31 4 Schoenberg Mark URGN Stock options (right to buy) A - Award D 29,41 15.000 15.000
2020-02-04 2020-01-31 4 Mullennix Stephen URGN Restricted stock unit A - Award D 3.000 3.000
2020-02-04 2020-01-31 4 Mullennix Stephen URGN Stock options (right to buy) A - Award D 29,41 15.000 15.000
2020-02-04 2020-01-31 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Unit A - Award D 6.000 6.000
2020-02-04 2020-01-31 4 PFREUNDSCHUH PETER P. URGN Stock options (right to buy) A - Award D 29,41 15.000 15.000
2020-01-28 2020-01-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 29,1500 -322 -9 9.177
2020-01-28 2020-01-26 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D -833 1.667
2020-01-28 2020-01-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 833 9.499
2020-01-28 2020-01-27 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 29,2600 -684 -20 8.665
2020-01-28 2020-01-26 4 Mullennix Stephen URGN Restricted Stock Units (RSUs) M - Exercise D -1.666 3.334
2020-01-28 2020-01-26 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1.666 9.349
2020-01-28 2020-01-27 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 29,2800 -667 -20 4.438
2020-01-28 2020-01-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units (RSUs) M - Exercise D -1.666 3.334
2020-01-28 2020-01-26 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1.666 5.105
2020-01-07 2020-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D -105.688 211.377
2020-01-07 2020-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 105.688 122.236
2019-12-05 2019-12-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D -1.042 4.167
2019-12-05 2019-12-04 4 Schoenberg Mark URGN Ordinary Shares F - Taxes D 31,6900 -343 -11 8.666
2019-12-05 2019-12-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.042 9.009
2019-11-22 2019-11-21 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 28,0000 7.530 211 16.548
2019-11-22 2019-11-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -1.042 7.291
2019-11-22 2019-11-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 28,4100 -354 -10 3.439
2019-11-22 2019-11-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1.042 3.793
2019-11-22 2019-11-20 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 28,0000 7.470 209 9.018
2019-11-21 2019-11-19 4 Schoenberg Mark By Mark Schoenberg Pension Plan FBO Mark Schoenberg URGN Ordinary Shares P - Purchase I 28,1700 1.960 55 7.967
2019-11-18 2019-11-15 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 26,0000 1.548 40 1.548
2019-11-18 2019-11-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D -1.759 8.796
2019-11-18 2019-11-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 25,9973 -608 -16 7.683
2019-11-18 2019-11-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1.759 8.291
2019-09-06 2019-09-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D -1.041 5.209
2019-09-06 2019-09-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 33,9200 -343 -12 6.007
2019-09-06 2019-09-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.041 6.350
2019-08-22 2019-08-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D -4.167 8.333
2019-08-22 2019-08-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 33,0700 -1.416 -47 2.751
2019-08-22 2019-08-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 4.167 4.167
2019-08-16 2019-08-15 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 31,6500 -608 -19 6.532
2019-08-16 2019-08-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D -1.759 10.555
2019-08-16 2019-08-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1.759 7.140
2019-06-06 2019-06-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D -1.042 6.250
2019-06-06 2019-06-04 4 Schoenberg Mark URGN Ordinary Shares F - Taxes D 35,0500 -343 -12 5.309
2019-06-06 2019-06-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.042 5.652
2019-06-05 2019-06-03 4 Belldegrun Arie URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-06-05 2019-06-03 4 Holden Stuart URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-06-05 2019-06-03 4 Nussbaum Ran URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-06-05 2019-06-03 4 Cohen Fred E URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-06-05 2019-06-03 4 BUTITTA CYNTHIA M URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-06-05 2019-06-03 4 FALBERG KATHRYN E URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-06-05 2019-06-03 4 Tomasello Shawn URGN Stock Option (Right to Buy) A - Award D 34,83 10.000 10.000
2019-05-16 2019-05-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D -1.759 12.314
2019-05-16 2019-05-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 37,9800 -608 -23 5.381
2019-05-16 2019-05-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1.759 5.989
2019-03-28 2019-03-27 4 Belldegrun Arie URGN Stock Option (right to buy M - Exercise D 4,02 4,0200 -128.000 -515 0
2019-03-28 2019-03-27 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 4,0200 128.000 515 212.211
2019-03-22 2019-02-06 4 Cohen Fred E URGN Stock Option (Right to Buy) M - Exercise D 16,99 -15.000 25.000
2019-03-22 2019-02-06 4 Cohen Fred E URGN Ordinary Shares M - Exercise D 16,9900 15.000 255 15.000
2019-03-22 2019-03-21 4 Schoenberg Mark URGN Ordinary Shares P - Purchase D 37,0090 272 10 4.610
2019-03-07 3/A Schoenberg Mark URGN Ordinary Shares D 5.287
2019-03-07 2019-02-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D -7.034 14.073
2019-03-07 2019-02-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 37,3000 -2.804 -105 4.230
2019-03-07 2019-02-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 7.034 7.034
2019-03-07 2019-03-06 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 37,3000 -1.991 -74 4.338
2019-03-07 2019-03-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D -1.042 7.292
2019-03-07 2019-03-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1.042 6.329
2019-01-29 2019-01-26 4 Schoenberg Mark URGN Restricted Stock Unit A - Award D 2.500 2.500
2019-01-29 2019-01-26 4 Schoenberg Mark URGN Employee Stock Option (right to buy) A - Award D 42,50 7.500 7.500
2019-01-29 2019-01-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Unit A - Award D 5.000 5.000
2019-01-29 2019-01-26 4 PFREUNDSCHUH PETER P. URGN Employee Stock Option (right to buy) A - Award D 42,50 15.000 15.000
2019-01-29 2019-01-26 4 Mullennix Stephen URGN Restricted Stock Unit A - Award D 5.000 5.000
2019-01-29 2019-01-26 4 Mullennix Stephen URGN Employee Stock Option (right to buy) A - Award D 42,50 15.000 15.000
2019-01-10 3 Belldegrun Arie URGN Ordinary Shares D 168.422
2019-01-10 3 Belldegrun Arie URGN Ordinary Shares D 168.422
2019-01-10 3 Belldegrun Arie URGN Ordinary Shares D 168.422
2019-01-10 3 BENTSUR RON URGN Ordinary Shares D 76.226
2019-01-10 3 BENTSUR RON URGN Ordinary Shares D 76.226
2019-01-10 3 BENTSUR RON URGN Ordinary Shares D 76.226
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 2.389.212
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 2.389.212
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 1.872.849
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 2.389.212
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 1.872.849
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 1.872.849
2019-01-10 3 PFREUNDSCHUH PETER P. URGN Ordinary Shares D 2.000
2019-01-10 3 PFREUNDSCHUH PETER P. URGN Ordinary Shares D 2.000
2019-01-10 3 PFREUNDSCHUH PETER P. URGN Ordinary Shares D 2.000
2019-01-10 3 Schoenberg Mark URGN Ordinary Shares D 2.242
2019-01-10 3 Schoenberg Mark URGN Ordinary Shares D 2.242
2019-01-10 3 Schoenberg Mark URGN Ordinary Shares D 2.242
2019-01-09 2018-01-03 4 Barrett Elizabeth A. URGN Restricted Stock Unit A - Award D 317.065 317.065
2019-01-09 2018-01-03 4 Barrett Elizabeth A. URGN Employee Stock Option (right to buy) A - Award D 47,57 277.432 277.432
2017-11-29 2017-11-28 4 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share S - Sale D 40,5100 -177.807 -7.203 1.242.031
2017-11-29 2017-11-27 4 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share S - Sale D 41,1200 -31.491 -1.295 1.419.838
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2.902.658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2.902.658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2.902.658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2.902.658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2.902.658
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:UR8 19,38 €
GB:0XOD 23,09 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista